Published in PLoS One on October 02, 2013
Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T. Magn Reson Med (2015) 0.80
Hyperbaric oxygen therapy improves cognitive functioning after brain injury. Neural Regen Res (2013) 0.77
Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T. NMR Biomed (2015) 0.77
Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using (1)H magnetic resonance spectroscopy at 7 T. Neuroscience (2017) 0.76
Physiological neuronal decline in healthy aging human brain - An in vivo study with MRI and short echo-time whole-brain (1)H MR spectroscopic imaging. Neuroimage (2016) 0.75
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med (1993) 15.51
Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed (2000) 8.18
Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed (2001) 6.56
RARE imaging: a fast imaging method for clinical MR. Magn Reson Med (1986) 6.17
Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med (1993) 5.48
In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med (1999) 4.26
Neural mechanisms of ageing and cognitive decline. Nature (2010) 3.59
Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med (2000) 3.13
Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson (1999) 2.42
N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev (1989) 2.28
In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med (2009) 2.27
Magnetic resonance spectroscopy of the human brain. Anat Rec (2001) 2.18
Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med (2002) 2.09
Changes in the structural complexity of the aged brain. Aging Cell (2007) 1.96
The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol (2003) 1.95
A half-volume coil for efficient proton decoupling in humans at 4 tesla. J Magn Reson (1997) 1.84
Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med (1994) 1.55
Diffusion NMR spectroscopy. NMR Biomed (2001) 1.43
A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex (2001) 1.38
Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson (2005) 1.25
Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology (1993) 1.19
Proton-observed carbon-edited NMR spectroscopy in strongly coupled second-order spin systems. Magn Reson Med (2006) 1.18
Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med (2005) 1.15
Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med (2008) 1.13
T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magn Reson Med (2010) 1.13
Anomalous transverse relaxation in 1H spectroscopy in human brain at 4 Tesla. Magn Reson Med (1995) 1.08
Estimation of brain iron concentration in vivo using a linear relationship between regional iron and apparent transverse relaxation rate of the tissue water at 4.7T. Magn Reson Med (2009) 1.01
Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol (2010) 0.99
The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging (1993) 0.98
Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H nuclear magnetic resonance spectroscopy of the monkey brain. J Cereb Blood Flow Metab (2006) 0.97
Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. Curr Genomics (2010) 0.97
(1)H MRS detection of glycine residue of reduced glutathione in vivo. J Magn Reson (2009) 0.94
Amino acid transport across the human blood-CSF barrier. An evaluation graph for amino acid concentrations in cerebrospinal fluid. J Neurol Sci (1985) 0.91
Proton MRS of early post-natal mouse brain modifications in vivo. NMR Biomed (2006) 0.89
Changes in the proton T2 relaxation times of cerebral water and metabolites during forebrain ischemia in rat at 9.4 T. Magn Reson Med (2003) 0.87
MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia. Neuroimage (2009) 0.86
A comparison of depressive mood of older adults in a community, nursing homes, and a geriatric hospital: factor analysis of Geriatric Depression Scale. J Geriatr Psychiatry Neurol (2006) 0.83
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
In vivo 13C spectroscopy in the rat brain using hyperpolarized [1-(13)C]pyruvate and [2-(13)C]pyruvate. J Magn Reson (2010) 1.33
Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci (2010) 1.12
Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med (2006) 1.09
Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study. NMR Biomed (2009) 1.08
Regional neurochemical profiles in the human brain measured by ¹H MRS at 7 T using local B₁ shimming. NMR Biomed (2011) 1.07
Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain. NMR Biomed (2011) 0.99
Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T. Magn Reson Med (2014) 0.96
Differences in apparent diffusion coefficients of brain metabolites between grey and white matter in the human brain measured at 7 T. Magn Reson Med (2011) 0.95
Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab (2011) 0.95
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clin Neuropharmacol (2013) 0.93
Simultaneous measurement of glucose transport and utilization in the human brain. Am J Physiol Endocrinol Metab (2011) 0.91
Noninvasive quantification of T2 and concentrations of ascorbate and glutathione in the human brain from the same double-edited spectra. NMR Biomed (2010) 0.87
Metabolic modeling of dynamic brain ¹³C NMR multiplet data: concepts and simulations with a two-compartment neuronal-glial model. Neurochem Res (2012) 0.87
Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease. J Cereb Blood Flow Metab (2012) 0.86
Cerebrovascular dynamics in patients with migraine: near-infrared spectroscopy study. Neurosci Lett (2006) 0.85
In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord (2015) 0.81
Rat brain MRI at 16.4T using a capacitively tunable patch antenna in combination with a receive array. NMR Biomed (2012) 0.80